Medical Xpress·4 min read·hard
GLP-1 drug linked to heart benefits for high-risk patients
B
British Medical Journal
✦AI Summary
A study published in The BMJ suggests that adding the drug tirzepatide to standard care for patients with type 2 diabetes and heart disease reduces the risk of major cardiovascular events. Researchers compared outcomes against sitagliptin to determine the drug's efficacy in high-risk patients.
edited by Gaby Clark , reviewed by Robert Egan
sciencehealth
✦
Get the full story
Sign up for Headlinne to unlock AI insights, political bias analysis, and your personalized news feed.
Create free accountAlready have an account? Sign in